INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr | ₹-23 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹361 Cr |
Mar2023 | ₹27 Cr |
Mar2022 | ₹125 Cr |
Mar2021 | ₹-19 Cr |
Mar2020 | ₹-23 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹361 Cr | 1,231.88 | |
Mar2023 | ₹27 Cr | -78.25 | |
Mar2022 | ₹125 Cr | Positive | |
Mar2021 | ₹-19 Cr | Negative | |
Mar2020 | ₹-23 Cr | - |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹4,950.1 Cr | -1.9% | -7.3% | 82% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | -1.9% |
-7.3% |
82% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses